We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SONO:NASDAQSonos, Inc. Analysis

Data as of 2026-05-02 - not real-time

$14.84

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Sonos (SONO) trades at $14.84, comfortably above its 20‑day and 50‑day moving averages but still below the 200‑day average, indicating a short‑term bullish bias within a longer‑term neutral trend. Technical momentum is supportive – RSI sits at 60, MACD shows a bullish crossover, and volume is increasing – while the price remains near a $15.20 resistance and well above a $12.73 support. The DCF‑derived fair value of $19.53 suggests roughly 29% upside, and analysts collectively rate the stock as a strong buy with a median price target of $19.50. However, the company posted a modest revenue decline of 0.9%, a negative profit margin and ROE, and relies on a forward EPS of $1.07 to justify its valuation. Upcoming Q2 results on May 4 will be a key catalyst, potentially confirming the upside narrative or exposing execution risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance with bullish MACD but earnings announcement imminent
  • High beta (~1.8) and 30‑day volatility above 30% increase downside risk
  • Increasing volume suggests market interest but uncertainty around near‑term earnings

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF upside of ~29% and analyst consensus strong‑buy
  • Improving cash generation (operating cash flow > $140M) and low net debt
  • Forward PE of ~14 versus industry PE of ~38 indicates value advantage

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Brand positioning in premium consumer audio with potential for subscription revenue
  • Undervalued relative to fair value and long‑term growth prospects
  • Strong balance sheet (cash > $360M, debt < $60M) supports strategic investments

Key Metrics & Analysis

Financial Health

Revenue Growth-0.90%
Profit Margin-1.22%
P/E Ratio13.9
ROE-3.85%
ROA2.31%
Debt/Equity13.36
P/B Ratio4.0
Op. Cash Flow$144.0M
Free Cash Flow$154.3M
Industry P/E38.5

Technical Analysis

TrendNeutral
RSI60.4
Support$12.73
Resistance$15.20
MA 20$14.13
MA 50$14.08
MA 200$15.25
MACDBullish
VolumeIncreasing
Fear & Greed Index91.09

Valuation

Fair Value$19.53
Target Price$19.13
Upside/Downside28.87%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.76
Volatility30.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.